Clinical presentations and phenotypes of the 27 MYO-SEQ index cases with suspected pathogenic variants in genes associated with dystroglycanopathies. Muscle pathology findings are defined as a replacement of muscle with fat on T1-weighted axial images. Radiology reports from referring centres are not standardised or quantitative. FVC = forced vital capacity; LVEF = left ventricular ejection fraction; LVFS = left ventricular fractional shortening; RNS = repetitive nerve stimulation. No indications = immunostaining was performed but was not suggestive of an α-DG deficiency. (XLSX 14 kb
Clinical characteristics and biopsy results of index cases for families studied. (DOCX 223 kb
Quality parameters and description of all mutations analyzed with Illumina VeraCode GoldenGate assay...
Figure S1. TEM of GRAF1 tibialis anterior muscle. TEM (Ă2500 magnification) reveals T-tubule abnorm...
List of variants in genes expressed in the human muscle and in genes whose mouse homologs are expres...
Clinical characteristics and WES results (including evidence of pathogenicity according to ACMG crit...
Background: Dystroglycanopathies are a clinically and genetically heterogeneous group of disorders t...
Lists of rare (< 1%) variants in genes related with “muscle phenotype” for individual patients. (XLS...
Dystrophin rescue is not preferential to a particular myofiber type. IF in serial sections were stai...
Selected genes with reported skeletal muscle expression which could contribute to LGMD. (DOCX 16 kb
NGS protocol and the list of genes in the neuromuscular disorder panel. (DOCX 20 kb
Figure S1. Loss of exercise capacity without change in hindlimb muscle mass. Figure S2. Altered torq...
PURPOSE: Several hundred genetic muscle diseases have been described, all of which are rare. Their c...
Table S1. Sequencing parameters. Table S2. Detailed information for primers used for Sanger sequenci...
Table S1. Oligonucleotide Sequences of 15 multiplex PCR sets and amplification size fragments. (DOCX...
Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of genetic disorders associated w...
Clinical characteristics and biopsy results of index cases for families studied. (DOCX 223 kb
Quality parameters and description of all mutations analyzed with Illumina VeraCode GoldenGate assay...
Figure S1. TEM of GRAF1 tibialis anterior muscle. TEM (Ă2500 magnification) reveals T-tubule abnorm...
List of variants in genes expressed in the human muscle and in genes whose mouse homologs are expres...
Clinical characteristics and WES results (including evidence of pathogenicity according to ACMG crit...
Background: Dystroglycanopathies are a clinically and genetically heterogeneous group of disorders t...
Lists of rare (< 1%) variants in genes related with “muscle phenotype” for individual patients. (XLS...
Dystrophin rescue is not preferential to a particular myofiber type. IF in serial sections were stai...
Selected genes with reported skeletal muscle expression which could contribute to LGMD. (DOCX 16 kb
NGS protocol and the list of genes in the neuromuscular disorder panel. (DOCX 20 kb
Figure S1. Loss of exercise capacity without change in hindlimb muscle mass. Figure S2. Altered torq...
PURPOSE: Several hundred genetic muscle diseases have been described, all of which are rare. Their c...
Table S1. Sequencing parameters. Table S2. Detailed information for primers used for Sanger sequenci...
Table S1. Oligonucleotide Sequences of 15 multiplex PCR sets and amplification size fragments. (DOCX...
Limb-girdle muscular dystrophies (LGMDs) are a heterogeneous group of genetic disorders associated w...
Clinical characteristics and biopsy results of index cases for families studied. (DOCX 223 kb
Quality parameters and description of all mutations analyzed with Illumina VeraCode GoldenGate assay...
Figure S1. TEM of GRAF1 tibialis anterior muscle. TEM (Ă2500 magnification) reveals T-tubule abnorm...